Update on Myopia Control: The US Perspective
- PMID: 35192563
- DOI: 10.1097/ICL.0000000000000872
Update on Myopia Control: The US Perspective
Abstract
Myopia is a global epidemic on the rise, garnering increased attention, particularly in therapeutics and prevention, and the field of myopia control. This study reviews the current management options including contact lenses, spectacles, atropine, and environmental and behavioral modifications. Particular attention is given to the US perspective.
Copyright © 2021 Contact Lens Association of Ophthalmologists.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016;123:1036–1042.
-
- Wong TY, Ferreira A, Hughes R, et al. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: An evidence-based systematic review. Am J Ophthalmol 2014;157:9–25.e12.
-
- Bullimore MA, Brennan NA. Myopia control: Why each diopter matters. Optom Vis Sci 2019;96:463–465.
-
- Walline JJ. Myopia control: A review. Eye Contact Lens 2016;42:3–8.
-
- Anstice NS, Phillips JR. Effect of dual-focus soft contact lens wear on axial myopia progression in children. Ophthalmology 2011;118:1152–1161.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical